Literature DB >> 7657822

Relationship of the 37,000- and 40,000-M(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512).

M A Payton1, C J Hawkes, M R Christie.   

Abstract

Sera from patients with insulin-dependent diabetes immunoprecipitate 64,000-M(r) proteins, distinct from glutamate decarboxylase, that are cleaved to 37,000- and 40,000-M(r) fragments by trypsin. We investigated possible relationships between 37,000- or 40,000-M(r) fragments of antigen and the tyrosine phosphatase-like protein, IA-2 (ICA512). Antibodies from nondiabetic relatives bound differentially to 37,000- and 40,000-M(r) fragments indicating presence of distinct epitopes. Precursors of these fragments could be separated on immobilized lectins, suggesting different carbohydrate content. Levels of antibodies to 40,000-M(r) fragments were strongly associated with those to the intracellular domain of IA-2. Recombinant intracellular domain of IA-2 blocked binding of antibodies to 40,000-M(r) fragments expressed by insulinoma cells and partially blocked binding to 37,000-M(r) fragments. Furthermore, trypsinization of recombinant intracellular domain of IA-2 generated proteolytic fragments of identical M(r) to the 40,000-M(r) fragments of insulinoma antigen; 37,000-M(r) fragments were not generated. Thus, 40,000-M(r) fragments of islet autoantigen are derived from a protein similar or identical to the tyrosine phosphatase-like molecule, IA-2. The 37,000-M(r) fragments are derived from a different, although related, protein.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7657822      PMCID: PMC185775          DOI: 10.1172/JCI118188

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  Antibodies to a Mr-64,000 islet cell protein in Swedish children with newly diagnosed type 1 (insulin-dependent) diabetes.

Authors:  M Christie; M Landin-Olsson; G Sundkvist; G Dahlquist; A Lernmark; S Baekkeskov
Journal:  Diabetologia       Date:  1988-08       Impact factor: 10.122

2.  Revelation of specificity of 64K autoantibodies in IDDM serums by high-resolution 2-D gel electrophoresis. Unambiguous identification of 64K target antigen.

Authors:  S Baekkeskov; G Warnock; M Christie; R V Rajotte; P M Larsen; S Fey
Journal:  Diabetes       Date:  1989-09       Impact factor: 9.461

3.  Persistence of serum antibodies to 64,000-Mr islet cell protein after onset of type I diabetes.

Authors:  M R Christie; D Daneman; P Champagne; T L Delovitch
Journal:  Diabetes       Date:  1990-06       Impact factor: 9.461

4.  Effects of sodium butyrate on proliferation-dependent insulin gene expression and insulin release in glucose-sensitive RIN-5AH cells.

Authors:  A E Karlsen; W Y Fujimoto; P Rabinovitch; S Dube; A Lernmark
Journal:  J Biol Chem       Date:  1991-04-25       Impact factor: 5.157

5.  Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins.

Authors:  S Baekkeskov; J H Nielsen; B Marner; T Bilde; J Ludvigsson; A Lernmark
Journal:  Nature       Date:  1982-07-08       Impact factor: 49.962

6.  Identification and cloning of a granule autoantigen (carboxypeptidase-H) associated with type I diabetes.

Authors:  L Castaño; E Russo; L Zhou; M A Lipes; G S Eisenbarth
Journal:  J Clin Endocrinol Metab       Date:  1991-12       Impact factor: 5.958

7.  Cloning and expression of IDDM-specific human autoantigens.

Authors:  D U Rabin; S M Pleasic; R Palmer-Crocker; J A Shapiro
Journal:  Diabetes       Date:  1992-02       Impact factor: 9.461

8.  Sera from patients with IDDM and healthy individuals have antibodies to ICA69 on western blots but do not immunoprecipitate liquid phase antigen.

Authors:  V Lampasona; M Ferrari; E Bosi; M R Pastore; P J Bingley; E Bonifacio
Journal:  J Autoimmun       Date:  1994-10       Impact factor: 7.094

9.  Insulin autoantibody polymorphisms with greater discrimination for diabetes in humans.

Authors:  T Wilkin; I Mirza; M Armitage; C Casey; L Scott-Morgan
Journal:  Diabetologia       Date:  1988-09       Impact factor: 10.122

10.  Distinct antibody specificities to a 64-kD islet cell antigen in type 1 diabetes as revealed by trypsin treatment.

Authors:  M R Christie; G Vohra; P Champagne; D Daneman; T L Delovitch
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

View more
  45 in total

Review 1.  The Sardinian way to type 1 diabetes.

Authors:  Marco Songini; Cira Lombardo
Journal:  J Diabetes Sci Technol       Date:  2010-09-01

2.  T-cell response to proinsulin and insulin in type 1 and pretype 1 diabetes.

Authors:  D Dubois-LaForgue; J C Carel; P F Bougnères; J G Guillet; C Boitard
Journal:  J Clin Immunol       Date:  1999-03       Impact factor: 8.317

3.  Mapping of novel autoreactive epitopes of the diabetes-associated autoantigen IA-2.

Authors:  J Seissler; M Schott; N G Morgenthaler; W A Scherbaum
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

4.  Autoantibodies and high-risk HLA susceptibility markers in first-degree relatives of Brazilian patients with type 1 diabetes mellitus: a progression to disease based study.

Authors:  L I Alves; E Davini; M R Correia; R T Fukui; R F Santos; M R Cunha; D M Rocha; W M G Volpini; M E R Silva
Journal:  J Clin Immunol       Date:  2012-03-09       Impact factor: 8.317

5.  IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus.

Authors:  M S Lan; C Wasserfall; N K Maclaren; A L Notkins
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

6.  Assignment of the IA-2 gene encoding an autoantigen in IDDM to chromosome 2q35.

Authors:  M S Lan; W S Modi; H Xie; A L Notkins
Journal:  Diabetologia       Date:  1996-08       Impact factor: 10.122

7.  Autoantibodies to IA-2 not detected in NOD mice or BB rats.

Authors:  M G DeSilva; H S Jun; J W Yoon; A L Notkins; M S Lan
Journal:  Diabetologia       Date:  1996-10       Impact factor: 10.122

8.  Stability of proICA512/IA-2 and its targeting to insulin secretory granules require β4-sheet-mediated dimerization of its ectodomain in the endoplasmic reticulum.

Authors:  Juha M Torkko; M Evangelina Primo; Ronald Dirkx; Anne Friedrich; Antje Viehrig; Elisa Vergari; Barbara Borgonovo; Anke Sönmez; Carolin Wegbrod; Martina Lachnit; Carla Münster; Mauricio P Sica; Mario R Ermácora; Michele Solimena
Journal:  Mol Cell Biol       Date:  2015-01-05       Impact factor: 4.272

9.  Humoral and cellular immune parameters before and during immunosuppressive therapy of a patient with stiff-man syndrome and insulin dependent diabetes mellitus.

Authors:  M Hummel; I Durinovic-Bello; E Bonifacio; V Lampasona; J Endl; S Fessele; F Then Bergh; C Trenkwalder; E Standl; A G Ziegler
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-08       Impact factor: 10.154

10.  Measurement of islet cell antibodies in the Type 1 Diabetes Genetics Consortium: efforts to harmonize procedures among the laboratories.

Authors:  Polly J Bingley; Alistair J K Williams; Peter G Colman; Shane A Gellert; George Eisenbarth; Liping Yu; Letitia H Perdue; June J Pierce; Joan E Hilner; Concepcion Nierras; Beena Akolkar; Michael W Steffes
Journal:  Clin Trials       Date:  2010       Impact factor: 2.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.